# Topotecan Pharmacokinetic Characterization Study

> **NCT00361803** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 15 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** topotecan

## Key facts

- **NCT ID:** NCT00361803
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09-12
- **Primary completion:** 2007-08-09
- **Final completion:** 2007-08-09
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2017-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00361803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00361803, "Topotecan Pharmacokinetic Characterization Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00361803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*